CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 2,046 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Molecular Therapy - Nucleic Acids
United States · Cell Press
workspace_premium Q1 — Drug Discovery visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Molecular Therapy - Nucleic Acids

Molecular Therapy - Nucleic Acids is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 104. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 3285 €. The scope of the journal is focused on development of therapeutics, vector development, RNA based therapeutics, gene modifying agents, safety studies. It has an SJR impact factor of 2,046 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,046.

Molecular Therapy - Nucleic Acids focuses its scope in these topics and keywords: dna, targeting, injury, aptamer, kidney, cells, rna, discovered, hairpin, accurate, ...

Publisher: Cell Press
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,046 Q1
H-index 104
Acceptance rate pie_chart
27% Selective
Source Acceptance_Rate
Time to publication hourglass_top
20 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
3.285 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

2,046

H-index

104

Docs (year)

274

Docs 3y

915

Total refs

15042

Cites 3y

5451

Citable 3y

829

Cites/Doc 2y

5.31

Ref/Doc

54.9

Immediate OA

3285 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Molecular Therapy - Nucleic Acids?

Molecular Therapy - Nucleic Acids has an SJR of 2,046 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 3285 EUR.

What is the acceptance rate?

The acceptance rate recorded for Molecular Therapy - Nucleic Acids is 27%.